Enzo Biochem Inc
Diagnostics & Research
Healthcare
ENZ
49.38 M shares
NYSE US
traded
02 Jan 2024
listed
no
open
1.38
52 week high
2.67
high
1.50
52 week low
1.32
low
1.33
growth
-1.32 %
previous Close
1.39
P/E ratio
market cap
80.56 M
div yield
0
usd
Apr 2023
qoq
revenue
16.11 M
-1.41 %
net incoming
-14.73 M
-38.22 %
eps
0.00 %
-33.70 %
eps surprise
0.00 %
net profit margin
-91.44 %
-26.00 %
operating incoming
-11.36 M
5.22 %
net change in cash
-2.42 M
65.80 %
cash on hand
2.63 M
-47.92 %
cost of revenue
14.47 M
-4.05 %
top top